Oracle Investment Management

Latest statistics and disclosures from ORACLE INVESTMENT MANAGEMENT's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are AXK, Tesaro, Mazor Robotics Ltd. equities, NXTM, QDEL. These five stock positions account for 69.17% of ORACLE INVESTMENT MANAGEMENT's total stock portfolio.
  • Added to shares of these 9 stocks: Tesaro (+$48.85M), PACB (+$16.27M), OPK (+$6.70M), BLTI (+$5.88M), Intrexon (+$5.69M), AMRN, shares Agenus, AXK, NXTM.
  • Reduced shares in these 2 stocks: HNSN (-$11.72M), Transition Therapeutics (-$5.61M).
  • Sold out of its positions in HNSN, Transition Therapeutics.
  • As of Sept. 30, 2016, ORACLE INVESTMENT MANAGEMENT has $648.94M in assets under management (AUM). Assets under management grew from a total value of $429.58M to $648.94M.
  • Independent of market fluctuations, ORACLE INVESTMENT MANAGEMENT was a net buyer by $68.44M worth of stocks in the most recent quarter.

ORACLE INVESTMENT MANAGEMENT portfolio companies for September 2016 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Accelr8 Technology Corporation (AXK) 21.39 5.09M 27.26 0.00
Tesaro 17.83 1.15M +73.00% 100.24 0.00
Mazor Robotics Ltd. equities 11.03 2.77M 25.87 0.00
NxStage Medical (NXTM) 10.29 2.67M 24.99 16.68
Quidel Corporation (QDEL) 8.62 2.53M 22.09 25.06
Opko Health (OPK) 7.42 4.55M +16.00% 10.59 14.08
Pacific Biosciences of California (PACB) 6.90 5.00M +57.00% 8.96 5.81
Biolase Technology (BLTI) 3.49 14.23M +35.00% 1.59 0.00
Amarin Corporation (AMRN) 3.00 6.09M +7.00% 3.19 1.94
Intrexon 2.86 662642 +44.00% 28.02 0.00
Accuray Incorporated (ARAY) 2.44 2.48M 6.37 8.54
shares Agenus 2.20 1.98M +6.00% 7.18 0.00
Vermillion (VRML) 1.73 8.62M 1.30 1.76
Contrafect 0.45 1.18M 2.48 0.00
Biogen Idec (BIIB) 0.32 6723 313.10 415.20
Second Sight Med Prods 0.03 50804 3.52 0.00
ZIOPHARM Oncology (ZIOP) 0.01 6661 5.70 13.14